These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18381488)

  • 1. Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. III. In vitro-in vivo correlation with fluconazole.
    Lu C; Berg C; Prakash SR; Lee FW; Balani SK
    Drug Metab Dispos; 2008 Jul; 36(7):1261-6. PubMed ID: 18381488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. II. In vitro-in vivo correlation with ketoconazole.
    Lu C; Hatsis P; Berg C; Lee FW; Balani SK
    Drug Metab Dispos; 2008 Jul; 36(7):1255-60. PubMed ID: 18381489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel model for the prediction of drug-drug interactions in humans based on in vitro cytochrome p450 phenotypic data.
    Lu C; Miwa GT; Prakash SR; Gan LS; Balani SK
    Drug Metab Dispos; 2007 Jan; 35(1):79-85. PubMed ID: 17020957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative prediction and clinical observation of a CYP3A inhibitor-based drug-drug interactions with MLN3897, a potent C-C chemokine receptor-1 antagonist.
    Lu C; Balani SK; Qian MG; Prakash SR; Ducray PS; von Moltke LL
    J Pharmacol Exp Ther; 2010 Feb; 332(2):562-8. PubMed ID: 19889796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of plasma and protein-free media incubation conditions.
    Mao J; Mohutsky MA; Harrelson JP; Wrighton SA; Hall SD
    Drug Metab Dispos; 2012 Apr; 40(4):706-16. PubMed ID: 22228749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of CYP3A-mediated drug-drug interactions using human hepatocytes suspended in human plasma.
    Mao J; Mohutsky MA; Harrelson JP; Wrighton SA; Hall SD
    Drug Metab Dispos; 2011 Apr; 39(4):591-602. PubMed ID: 21212240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction.
    Kunze KL; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):429-35. PubMed ID: 8801058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions.
    Obach RS; Walsky RL; Venkatakrishnan K
    Drug Metab Dispos; 2007 Feb; 35(2):246-55. PubMed ID: 17093004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
    Black DJ; Kunze KL; Wienkers LC; Gidal BE; Seaton TL; McDonnell ND; Evans JS; Bauwens JE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):422-8. PubMed ID: 8801057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-drug interaction of antifungal drugs].
    Niwa T; Shiraga T; Takagi A
    Yakugaku Zasshi; 2005 Oct; 125(10):795-805. PubMed ID: 16205037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo.
    Donato MT; Hallifax D; Picazo L; Castell JV; Houston JB; Gomez-Lechón MJ; Lahoz A
    Drug Metab Dispos; 2010 Sep; 38(9):1449-55. PubMed ID: 20501911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral ketoconazole on oral and intravenous pharmacokinetics of simvastatin and its acid in cynomolgus monkeys.
    Ogasawara A; Utoh M; Nii K; Ueda A; Yoshikawa T; Kume T; Fukuzaki K
    Drug Metab Dispos; 2009 Jan; 37(1):122-8. PubMed ID: 18854378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition.
    Neal JM; Kunze KL; Levy RH; O'Reilly RA; Trager WF
    Drug Metab Dispos; 2003 Aug; 31(8):1043-8. PubMed ID: 12867493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated in vitro analysis for the in vivo prediction of cytochrome P450-mediated drug-drug interactions.
    McGinnity DF; Waters NJ; Tucker J; Riley RJ
    Drug Metab Dispos; 2008 Jun; 36(6):1126-34. PubMed ID: 18356267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships.
    Ervine CM; Matthew DE; Brennan B; Houston JB
    Drug Metab Dispos; 1996 Feb; 24(2):211-5. PubMed ID: 8742233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations.
    Karonen T; Laitila J; Niemi M; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2012 May; 68(5):681-8. PubMed ID: 22108774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole serum concentrations and pharmacokinetics in an obese patient.
    Cohen LG; DiBiasio A; Lisco SJ; Hurford WE
    Pharmacotherapy; 1997; 17(5):1023-6. PubMed ID: 9324192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of CYP2C9-mediated drug-drug interactions: a comparison using data from recombinant enzymes and human hepatocytes.
    McGinnity DF; Tucker J; Trigg S; Riley RJ
    Drug Metab Dispos; 2005 Nov; 33(11):1700-7. PubMed ID: 16081671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.